½ÃÀ庸°í¼­
»óǰÄÚµå
1495978

¼¼°èÀÇ ¼ö¼ú¿ë °¡¿î ½ÃÀå - ¿¹Ãø(2024-2029³â)

Global Surgical Gowns Market - Forecasts from 2024 to 2029

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Knowledge Sourcing Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 146 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼ö¼ú¿ë °¡¿î ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ 3.22%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2022³â 9¾ï 6,642¸¸ 3,000´Þ·¯¿¡¼­ 2029³â 12¾ï 922¸¸ 7,000´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼ö¼ú¿ë °¡¿îÀº ÀÇ·áÁøÀÌ ¼ö¼ú ½Ã »ç¿ëÇÏ´Â º¸È£ Àåºñ·Î, ȯÀÚÀÇ °Ç°­¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö Àִ ȯÀÚ¿ÍÀÇ ¹Ì»ý¹° °¨¿°À» ¹æÁöÇϱâ À§ÇØ »ç¿ëµË´Ï´Ù. °¡¿îÀº ¸éÀ̳ª Æú¸®¿¡½ºÅ׸£ Á÷¹°°ú °°Àº Á÷¹°·Î ¸¸µé¾îÁ® Æí¾ÈÇÔÀÌ ¶Ù¾î³ª¸ç, ¸ÂÃãÇü µðÀÚÀεµ °¡´ÉÇÕ´Ï´Ù.

ÀÇ·á ºÎ¹®ÀÇ ±Þ¼ÓÇÑ ¹ßÀü, º´¿ø ¹× ÀÇ·á ½Ã¼³ÀÇ Áõ°¡, ÀÇ·á º¸È£ ÀåºñÀÇ ±â¼ú Çõ½Å°ú ÇÔ²² ¼ö¼ú °Ç¼ö Áõ°¡, ³ëÀÎ Àα¸ÀÇ ±Þ¼ÓÇÑ Áõ°¡´Â ¼ö¼ú °¡¿î¿¡ ´ëÇÑ ½ÃÀå ¼ö¿ä¸¦ Áõ°¡½ÃŰ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2019³â 8¿ù Àεµ Á¤ºÎ´Â Àü±¹ °¢Áö¿¡ 22°³ÀÇ AIIMS º´¿øÀ» »õ·Î ¼³¸³ÇÒ °ÍÀ̶ó°í ¹ßÇ¥Çß½À´Ï´Ù.

¶ÇÇÑ, ¹Ì±¹ ³ëµ¿Åë°èû ÀÚ·á¿¡ µû¸£¸é 2019³â 3ºÐ±â ±âÁØ ¹Ì±¹ ³» º´¿ø ½Ã¼³Àº ÃÑ 1¸¸ 3,944°³¿¡ ´ÞÇÕ´Ï´Ù. ÀÌ·¯ÇÑ »ç¾÷ÀåÀÇ Áõ°¡¿¡ µû¶ó ¼ö¼ú¿ë °¡¿îÀ» Æ÷ÇÔÇÑ ÀÇ·á Àåºñ ¹× ŰƮ¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡ÇÏ¿© ¼ö¼ú¿ë °¡¿î ½ÃÀåÀÇ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °¡¿î À¯Çü¿¡ µû¶ó ½ÃÀå ¼¼ºÐÈ­´Â ¼ö¼ú¿ë °Ý¸® °¡¿î, ºñ°­È­ °¡¿î, °­È­ °¡¿î, °­È­ °¡¿î, ±âŸ·Î ±¸ºÐµË´Ï´Ù.

¼ö¼ú¿ë °Ý¸® °¡¿îÀº ¼ö¼ú¿ë °¡¿î ½ÃÀå ¿¹Ãø ±â°£ µ¿¾È ºñ±³Àû ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼ö¼ú¿ë °Ý¸® °¡¿îÀº ¿À¿° À§ÇèÀÌ Áß°£¿¡¼­ ³ôÀº ¼ö¼ú¿¡¼­ ³ôÀº Àû¿ë °¡´É¼ºÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ³ëÀÎ Àα¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¼ö¼ú ±Ô¸ðµµ Áõ°¡Çϰí ÀÖÀ¸¸ç, °Ý¸® °¡¿î°ú °°Àº ¼ö¼ú °¡¿î¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ÃËÁø¿äÀÎ:

  • °¢±¹ÀÇ ¼ö¼ú °Ç¼ö°¡ ±Þ°ÝÈ÷ Áõ°¡ÇÔ¿¡ µû¶ó ¼ö¼ú °¡¿î¿¡ ´ëÇÑ ¼ö¿ä¿Í ¼Òºñ°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼ö¼ú¿ë °¡¿îÀº ÀÇ·áÁø°ú ȯÀÚ »çÀÌ¿¡ À庮À» ¸¸µé¾î ¿À¿°°ú ¿øÄ¡ ¾Ê´Â °¨¿°À» ¹æÁöÇÕ´Ï´Ù. ¼ö³â µ¿¾È ´Ù¾çÇÑ ÀÇ·á ºÎ¹®°ú °ü·ÃµÈ ¿Ü°ú ¼ö¼úÀÇ ¼ö´Â ºÎÀûÀýÇÑ ¿µ¾ç ¼·Ãë¿Í ÁÂ½Ä »ýȰ ¹æ½ÄÀÇ Áõ°¡·Î ÀÎÇØ ¿Ü°ú Àû Ä¡·á°¡ ÇÊ¿äÇÑ »ç¶÷µéÀÇ ´Ù¾çÇÑ °Ç°­ ¹®Á¦ÀÇ ºñÀ²À» Áõ°¡½ÃÄÑ ¿Ü°ú Àû Ä¡·á°¡ ÇÊ¿äÇÑ »ç¶÷µéÀÇ ºñÀ²ÀÌ Å©°Ô Áõ°¡Çß½À´Ï´Ù.

¿¹¸¦ µé¾î, Eurostat¿¡ µû¸£¸é 2020³â À¯·´¿¬ÇÕ ±¹°¡ Àüü¿¡¼­ 366¸¸ °ÇÀÇ ¹é³»Àå ¼ö¼úÀÌ ÀÌ·ç¾îÁ³À¸¸ç, º§±â¿¡, ¸ôŸ, ŰÇÁ·Î½º, ±×¸®½º´Â Áö³­Çغ¸´Ù 122¸¸ °ÇÀÇ ¼ö¼úÀÌ Å©°Ô Áõ°¡Çß´Ù°í ÇÕ´Ï´Ù. ¶ÇÇÑ Àεµ º¸°Ç°¡Á·º¹ÁöºÎÀÇ 2021-2022 ¿¬·Ê º¸°í¼­¿¡ µû¸£¸é 2021³â 1¿ùºÎÅÍ 9¿ù±îÁö ÀεµÀÇ ±Í, ÄÚ, ¸ñ ¼ö¼ú °Ç¼ö´Â 15,374°ÇÀ̾ú½À´Ï´Ù. ÀÌ´Â ÇØ´ç ±â°£ÀÇ 2020³â ´ëºñ ´«, ÄÚ, ¸ñ ¼ö¼úÀÌ 54.5% Áõ°¡ÇÑ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

ÀÌ·¯ÇÑ ¼ö¼ú °Ç¼öÀÇ Áõ°¡¿¡ µû¶ó ¼ö¼ú¿ë °¡¿îÀÇ ¼ö¿ä¿Í ¼Òºñµµ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â ¿¹Ãø ±â°£ µ¿¾È ¼ö¼ú¿ë °¡¿î' ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±×·¯³ª ´Ù¾çÇÑ ÀÇ·á ¹× ¿Ü°ú ¼ö¼ú¿¡ »ç¿ëµÇ´Â ¼ö¼ú °¡¿îÀº ƯÁ¤ ¿ä±¸ »çÇ×À» ÃæÁ·ÇؾßÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ½ÄǰÀǾ౹(FDA)ÀÌ Á¤ÇÑ ÀÎ½ÄµÈ ÇÕÀÇ Ç¥ÁØÀº ¸ê±Õ ±âÁذú »ýü ÀûÇÕ¼º ±âÁØÀ¸·Î ±¸¼ºµÇ¾î ÀÖÀ¸¸ç, ¼ö¼ú °¡¿î Á¦Á¶¾÷ü´Â À̸¦ ÃæÁ·ÇØ¾ß ÇÕ´Ï´Ù. À¯·´¿¬ÇÕÀÇ À¯·´Ç¥ÁØÈ­À§¿øÈ¸(European Committee for Standardization)µµ À¯»çÇÑ °¡À̵å¶óÀÎÀ» Á¦Á¤Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °¡À̵å¶óÀΰú ±âÁØÀº ¼¼°è ¼ö¼ú¿ë °¡¿î ½ÃÀåÀÇ ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

ºÏ¹Ì°¡ ¼ö¼ú¿ë °¡¿î ½ÃÀåÀ» µ¶Á¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì ÀÇ·á ÀÎÇÁ¶ó, ƯÈ÷ ¹Ì±¹°ú ij³ª´ÙÀÇ ÀÇ·á ÀÎÇÁ¶ó´Â ¼ö¼ú¿ë °¡¿îÀ» Æ÷ÇÔÇÑ °íǰÁú ÀÇ·á¿ë ¼¶À¯ Á¦Ç°À» ÇÊ¿ä·Î Çϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ¾ö°ÝÇÑ °¨¿° °ü¸® ±âÁذú FDA ¹× ij³ª´Ù º¸°ÇºÎ¿Í °°Àº ±ÔÁ¦ ±â°üÀº ÀÇ·á¿ë ¼¶À¯ Á¦Ç°ÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇÏ¿© ½ÃÀå ¿ìÀ§¸¦ È®º¸Çϰí ÀÖ½À´Ï´Ù.

³ôÀº ÀÇ·áºñ ÁöÃâ ¼öÁذú ¸¸¼º ÁúȯÀÇ È®»êÀº ¼ö¼ú¿ë °¡¿î¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ÁÖ¿ä ½ÃÀå ÁøÀÔ ±â¾÷µéÀº ¼ö¼ú¿ë °¡¿îÀÇ ¾ÈÁ¤ÀûÀÎ °ø±ÞÀ» º¸ÀåÇÏ°í ±â¼ú Çõ½Å°ú °æÀïÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ¼¶À¯ÀÇ ±â¼ú ¹ßÀüµµ °è¼Ó ¹ßÀüÇϰí ÀÖÀ¸¸ç, Áö¼ÓÀûÀÎ ¿¬±¸´Â ¼ö¼ú °¡¿îÀÇ ¼ÒÀç, µðÀÚÀÎ, ±â´ÉÀÇ Çõ½Å¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì ÀÇ·á ½ÃÀåÀÇ ¿ìÀ§´Â ¼¼°è ½ÃÀå ¿ªÇп¡ ¿µÇâÀ» ¹ÌÄ¡°í ±¹³» ¼ö¿ä¿Í ¼¼°è ½ÃÀå ¿ªÇÐÀ» ¹Ý¿µÇÕ´Ï´Ù.

ÁÖ¿ä °³¹ß

  • 2023³â 9¿ù - Ä«µð³Î Çコ(Cardinal Health)°¡ ¹Ì±¹¿¡¼­ ¾î½Ã½ºÆ®(Assist(TM) ±â±â Æ÷ÄÏÀÌ ÀÖ´Â ½º¸¶Æ® °¡¿î(TM) ¿§Áö Åë±â¼º ¼ö¼ú¿ë °¡¿îÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ °¡¿îÀº ¼ö¼ú Áß ¼ö¼ú µµ±¸¿¡ ¾ÈÀüÇÏ°í Æí¸®ÇÏ°Ô Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÆ½À´Ï´Ù. °¢ Æ÷ÄÏ¿¡ ±ÇÀå ±â±¸ 1°³¾¿À» ¼ö³³ÇÒ ¼ö ÀÖ¾î ÀÓ»óÆÀÀÌ È¯ÀÚ Ä¡·á¿¡ ÁýÁßÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. Ä«µð³Î Çコ, ¸ÞÀÌ¿ä Ŭ¸®´Ð, °øµ¿ ¹ß¸í°¡ÀÎ Joseph Dearani¿Í Salim WaljiÀÇ Çù¾÷À¸·Î ½Ã°£ Àý¾à°ú ÀÚ±ÞÀÚÁ·ÀÇ °¡´É¼ºÀ» ÃËÁøÇÕ´Ï´Ù. ÀÚ±ÞÀÚÁ·ÀÇ °¡´É¼ºÀ» ÃËÁøÇÕ´Ï´Ù.
  • 2023³â 2¿ù - ¹Ì±¹ ÀÇ·á±â±â ÁøÈï Çùȸ(AAMI)´Â ¼ö¼ú °¡¿î, °Ý¸® °¡¿î, º¸È£º¹, ¼ö¼ú¿ë µå·¹ÀÌÇÁ ¹× µå·¹ÀÌÇÁ ¾×¼¼¼­¸®¿¡ ´ëÇÑ ¼º´É ¿ä±¸ »çÇ×À» ¼³¸íÇÏ´Â ÃֽŠ¹Ì±¹ ±¹°¡ Ç¥ÁØ ANSI/AAMI PB70À» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Ç¥ÁØÀº ¼ö¼ú Áß ÀÇ·á Á¾»çÀÚ¸¦ º¸È£Çϱâ À§ÇØ ÀÌ·¯ÇÑ Ç°¸ñÀÇ È¿°ú¸¦ º¸ÀåÇÏ´Â °ÍÀ» ¸ñÇ¥·ÎÇÕ´Ï´Ù.
  • 2022³â 6¿ù - ¹öÁö´Ï¾Æ º´¿ø ½Ã½ºÅÛ(The Virginia Hospital System)Àº COVID-19·Î ÀÎÇÑ °ø±Þ¸Á ¹× ȯ°æ ¿µÇâ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ Àç»ç¿ë °¡´ÉÇÑ °Ý¸® °¡¿îÀ» °³¹ßÇßÀ¸¸ç, Inova Health SystemÀÌ ¼³°èÇÑ ÀÌ °¡¿îÀº ¿¬°£ 213ÅæÀÇ Æó±â¹°À» Á¦°ÅÇÏ´Â ¸ÂÃãÇü Àç»ç¿ë °¡´ÉÇÑ ¼Ö·ç¼ÇÀÔ´Ï´Ù. ÀÇ Æó±â¹°À» ¾ø¾Ö´Â ¸ÂÃãÇü Àç»ç¿ë °¡´ÉÇÑ ¼Ö·ç¼ÇÀÔ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀÌ ±âÁ¸¿¡ »ç¿ëÇÏ´ø °¡¿îÀº ´õ Æí¾ÈÇÏ°í ½Ã¿øÇϸç 100¹ø±îÁö Àç»ç¿ëÇÒ ¼ö ÀÖ¾î Áö¼Ó°¡´É¼ºÀ» À§ÇÑ ³ë·Â¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀÇ ¼º°øÀº °¨¿°°ü¸®¿ªÇÐÀü¹®°¡ÇùȸÀÇ Á¦49ȸ ¿¬·Ê ÄÁÆÛ·±½º¿¡¼­ ¹ßÇ¥µÇ¾ú½À´Ï´Ù.
  • 2022³â 3¿ù - nvenio´Â V90 ¼ö¼ú °¡¿î ½Ã¸®Á ¹ßÇ¥Çߴµ¥, V90 ¼ö¼ú °¡¿î ½Ã¸®Áî´Â ÀÇ·á ȯ°æÀÇ ¾ö°ÝÇÔÀ» ÃæÁ·½ÃŰ¸é¼­ ºñ¿ë ±ÕÇüÀ» °í·ÁÇÑ »õ·Î¿î ¼ö¼ú °¡¿î ½Ã¸®ÁîÀÔ´Ï´Ù. ÀÌ °¡¿îÀº À½ÆÄ ¿ëÁ¢, ºÎµå·¯¿î ´ÏÆ® Ä¿ÇÁ½º, Á¶ÀýÀÌ °¡´ÉÇϰí Àüü Ä¿¹ö¸®Áö¸¦À§ÇÑ ¾ó±¼ ÆÐ½º³Ê¸¦ °®Ãß°í ÀÖ½À´Ï´Ù. ºñ°­È­, Á÷¹° ¹× Çʸ§ °­È­ ¼º´É ¿É¼ÇÀ» ÅëÇØ »ç¿ëÀÚ´Â ½Ã¼ú¿¡ ÀûÇÕÇÑ °¡¿îÀ» ¼±ÅÃÇÒ ¼ö ÀÖÀ¸¸ç, V90 ¼ö¼ú °¡¿î ½Ã¸®Áî´Â ȸ»çÀÇ ¼ö¼ú °¡¿î Æ÷Æ®Æú¸®¿À¿¡¼­ Áß¿äÇÑ ÁøÀüÀ» ÀÌ·ì´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

  • ½ÃÀå °³¿ä
  • ½ÃÀå Á¤ÀÇ
  • Á¶»ç ¹üÀ§
  • ½ÃÀå ¼¼ºÐÈ­
  • ÅëÈ­
  • °¡Á¤
  • ±âÁØ ¿¬µµ¿Í ¿¹Ãø ¿¬µµ ŸÀÓ¶óÀÎ
  • ÀÌÇØ°ü°èÀÚ¿¡ ´ëÇÑ ÁÖ¿ä ÀÌÁ¡

Á¦2Àå Á¶»ç ¹æ¹ý

  • Á¶»ç µðÀÚÀÎ
  • Á¶»ç °úÁ¤

Á¦3Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä Á¶»ç °á°ú

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • Porter's Five Forces ºÐ¼®
  • ¾÷°è ¹ë·ùüÀÎ ºÐ¼®
  • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ

Á¦5Àå ¼ö¼ú¿ë °¡¿î ¼¼°è ½ÃÀå : Á÷¹° À¯Çüº°

  • ¼Ò°³
  • ÄÚÆ°
  • Æú¸®¿¡½ºÅ׸£
  • ±âŸ

Á¦6Àå ¼ö¼ú¿ë °¡¿î ¼¼°è ½ÃÀå : º¹Àå À¯Çüº°

  • ¼Ò°³
  • ¼ö¼ú¿ë °Ý¸® °¡¿î
  • ºñ°­È­ °¡¿î
  • °­È­ °¡¿î
  • ±âŸ

Á¦7Àå ¼ö¼ú¿ë °¡¿î ¼¼°è ½ÃÀå : »ç¿ë ÆÐÅϺ°

  • ¼Ò°³
  • Àç»ç¿ë °¡´É
  • ÀÏȸ¿ë

Á¦8Àå ¼ö¼ú¿ë °¡¿î ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼Ò°³
  • º´¿ø¡¤Å¬¸®´Ð
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ

Á¦9Àå ¼ö¼ú¿ë °¡¿î ¼¼°è ½ÃÀå : Áö¿ªº°

  • ¼Ò°³
  • ºÏ¹Ì
  • ³²¹Ì
  • À¯·´
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ¾Æ½Ã¾ÆÅÂÆò¾ç

Á¦10Àå °æÀï ȯ°æ°ú ºÐ¼®

  • ÁÖ¿ä ±â¾÷°ú Àü·« ºÐ¼®
  • ½ÃÀå Á¡À¯À² ºÐ¼®
  • ÇÕº´, Àμö, ÇÕÀÇ¿Í Çù¾÷
  • °æÀï ´ë½Ãº¸µå

Á¦11Àå ±â¾÷ °³¿ä

  • Cardinal Health
  • CWS International GmbH
  • Molnlycke Health Care AB
  • O&M Halyard
  • Priontex
  • Cortex Products Solution Pvt. Ltd
  • Thermo Fisher Scientific
  • 3M
  • Medica Europe BV
  • Whelehan Group
ksm 24.06.24

The global surgical gowns market is expected to grow at a CAGR of 3.22% over the forecast period to reach US$1,209.227 million by 2029 from US$966.423 million in 2022.

Surgical gowns are protective equipment used by medical and healthcare professionals during surgical procedures to prevent microbial transmission between them and the patient that could affect their health. The gowns are made from fabrics such as cotton and woven polyester, among others, that provide a greater comfort level and can also be custom-designed.

Rapid developments in the medical care sector, growing establishments of hospitals & healthcare facilities, an increase in the number of surgeries coupled with innovation in medical protective gear, and a rapidly growing old age population are the major factors boosting the market demand for surgical gowns. For instance, in August 2019, the Government of India announced the establishment of 22 new AIIMS hospitals in different parts of the country.

Furthermore, according to the data provided by the US Bureau of Labor Statistics, in Q3 of 2019, hospital establishments in the US stood at a total of 13,944. With such growing establishments, the demand for medical equipment and kits, including surgical gowns, has also increased, thereby stimulating the market growth of the surgical gowns market. Based on gown type, the global surgical gowns market is segmented into surgical isolation gowns, non-reinforced gowns, reinforced gowns, and others.

The surgical isolation gowns are expected to grow at a relatively higher rate during the forecast period of the global surgical gowns market. Surgical isolation gowns have high applicability in surgical procedures in which the risk of contamination ranges from medium to high. With the increase in the old age population, the scale of surgical procedures has also increased, which is expected to create more demand for surgical gowns, such as isolation gowns is also expected to increase.

Market Drivers:

  • The rapid increase in the number of surgical procedures in countries is expected to increase the demand and consumption of surgical gowns.

Surgical gowns create a barrier between the medical professional and the patient, thereby preventing them from contamination and unwanted infections. Over the years, the number of surgical procedures relating to different medical fields has witnessed a significant increase owing to the growing improper nutritional intake and sedentary lifestyle, which has increased the rate of various health issues in people who require surgical treatment.

For instance, according to Eurostat, in 2020, Cataract surgery was conducted on 3.66 million people across the European Union countries, Belgium, Malta, Cyprus, and Greece showed a significant increase from the last year of 1.22 million surgical procedures. Furthermore, according to the 2021-2022 Annual Report of the Ministry of Health and Family Welfare, from January to September 2021, the number of ear, nose, and throat surgeries in India stood at 15,374. This showed an increase of 54.5% in surgical procedures for eyes, nose, and throat in comparison to 2020 for the corresponding period.

With such an increase in the number of surgical procedures, the demand and consumption of surgical gowns are also projected to increase, thereby positively impacting the global surgical gowns' market growth during the forecast period.

However, surgical gowns to be used in various medical and surgical procedures must fulfill certain requirements. For instance, the Recognized Consensus Standards laid down by the FDA consist of sterility standards and biocompatibility standards, which the makers of surgical gowns are required to meet. Similar guidelines have been laid by the European Union's European Committee for Standardization. Such guidelines and standards can create obstacles in the global surgical gown market growth.

North America region is predicted to dominate the global surgical gowns market.

North America's healthcare infrastructure, particularly in the United States and Canada, necessitates high-quality medical textiles, including surgical gowns. The region's stringent infection control standards and regulatory bodies like the FDA and Health Canada ensure the safety and effectiveness of medical textiles, boosting its market dominance.

The high healthcare expenditure levels and prevalence of chronic diseases further fuel demand for surgical gowns. Key market players ensure a steady supply of surgical gowns, facilitating innovation and competition.

Technological advancements in medical textiles are also being made, with ongoing research contributing to the innovation of surgical gown materials, designs, and features. The North American healthcare market's dominance impacts global market dynamics, reflecting internal demands and global market dynamics.

Key Developments:

  • September 2023- Cardinal Health launched its SmartGown(TM) EDGE Breathable Surgical Gown with ASSIST(TM) Instrument Pockets in the US. The gown is designed to provide safe and convenient access to surgical instruments during procedures. It holds one recommended instrument per pocket, allowing clinical teams to focus on patient care. The gown's chest pockets keep frequently used instruments within easy reach, minimizing contamination and unintentional instrument drops. The collaboration between Cardinal Health, Mayo Clinic, and co-inventors Joseph Dearani and Salim Walji promotes potential time savings and self-sufficiency.
  • February 2023- The Association for the Advancement of Medical Instrumentation (AAMI) released an updated American National Standard, ANSI/AAMI PB70, outlining performance requirements for surgical gowns, isolation gowns, protective apparel, surgical drapes, and drape accessories. The standard aims to ensure the effectiveness of these items in safeguarding healthcare workers during surgeries. It establishes minimum barrier performance requirements, a classification system, and associated labeling requirements for protective apparel, surgical drapes, and drape accessories in healthcare facilities.
  • June 2022- The Virginia Hospital System developed a reusable isolation gown to address supply chain and environmental impact issues caused by COVID-19. The gown, designed by Inova Health System, is a custom, reusable solution that eliminates 213 tons of waste annually. The gowns, which were previously used by the system, are more comfortable, cooler, and can be reused up to 100 times, contributing to sustainability efforts. The success of this innovative solution was presented at the Association for Professionals in Infection Control and Epidemiology's 49th Annual Conference.
  • March 2022- Invenio introduced the V90 surgical gown series, a new range of surgical gowns designed to meet the rigors of the healthcare environment while balancing cost. The gowns feature sonic welding, soft knit cuffs, and a hook and loop closure for adjustability and full coverage. They offer non-reinforced, fabric, and film-reinforced performance options, allowing users to select the appropriate gown for their procedure. The V90 surgical gown series is a significant step forward in the company's surgical gown portfolio.

Market Segmentation:

By Fabric Type

  • Cotton
  • Polyester
  • Others

By Gown Type

  • Surgical Isolation
  • Non-Reinforced Gown
  • Reinforced Gown
  • Others

By Usage Pattern

  • Reusable
  • Disposable

By End-User

  • Hospitals & Clinics
  • Ambulatory Surgical Center

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • United Arab Emirates
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL SURGICAL GOWNS MARKET BY FABRIC TYPE

  • 5.1. Introduction
  • 5.2. Cotton
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Polyester
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Others
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness

6. GLOBAL SURGICAL GOWNS MARKET BY GOWN TYPE

  • 6.1. Introduction
  • 6.2. Surgical Isolation
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Non-Reinforced Gown
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Reinforced Gown
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. Others
    • 6.5.1. Market Opportunities and Trends
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness

7. GLOBAL SURGICAL GOWNS MARKET BY USAGE PATTERN

  • 7.1. Introduction
  • 7.2. Reusable
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Disposable
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness

8. GLOBAL SURGICAL GOWNS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
    • 8.2.1. Market Opportunities and Trends
    • 8.2.2. Growth Prospects
    • 8.2.3. Geographic Lucrativeness
  • 8.3. Ambulatory Surgical Centre
    • 8.3.1. Market Opportunities and Trends
    • 8.3.2. Growth Prospects
    • 8.3.3. Geographic Lucrativeness

9. GLOBAL SURGICAL GOWNS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Fabric Type
    • 9.2.2. By Gown Type
    • 9.2.3. By Usage Pattern
    • 9.2.4. By End-User
    • 9.2.5. By Country
      • 9.2.5.1. USA
        • 9.2.5.1.1. Market Opportunities and Trends
        • 9.2.5.1.2. Growth Prospects
      • 9.2.5.2. Canada
        • 9.2.5.2.1. Market Opportunities and Trends
        • 9.2.5.2.2. Growth Prospects
      • 9.2.5.3. Mexico
        • 9.2.5.3.1. Market Opportunities and Trends
        • 9.2.5.3.2. Growth Prospects
  • 9.3. South America
    • 9.3.1. By Fabric Type
    • 9.3.2. By Gown Type
    • 9.3.3. By Usage Pattern
    • 9.3.4. By End-User
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
        • 9.3.5.1.1. Market Opportunities and Trends
        • 9.3.5.1.2. Growth Prospects
      • 9.3.5.2. Argentina
        • 9.3.5.2.1. Market Opportunities and Trends
        • 9.3.5.2.2. Growth Prospects
      • 9.3.5.3. Others
        • 9.3.5.3.1. Market Opportunities and Trends
        • 9.3.5.3.2. Growth Prospects
  • 9.4. Europe
    • 9.4.1. By Fabric Type
    • 9.4.2. By Gown Type
    • 9.4.3. By Usage Pattern
    • 9.4.4. By End-User
    • 9.4.5. By Country
      • 9.4.5.1. Germany
        • 9.4.5.1.1. Market Opportunities and Trends
        • 9.4.5.1.2. Growth Prospects
      • 9.4.5.2. France
        • 9.4.5.2.1. Market Opportunities and Trends
        • 9.4.5.2.2. Growth Prospects
      • 9.4.5.3. United Kingdom
        • 9.4.5.3.1. Market Opportunities and Trends
        • 9.4.5.3.2. Growth Prospects
      • 9.4.5.4. Italy
        • 9.4.5.4.1. Market Opportunities and Trends
        • 9.4.5.4.2. Growth Prospects
      • 9.4.5.5. Spain
        • 9.4.5.5.1. Market Opportunities and Trends
        • 9.4.5.5.2. Growth Prospects
      • 9.4.5.6. Others
        • 9.4.5.6.1. Market Opportunities and Trends
        • 9.4.5.6.2. Growth Prospects
  • 9.5. Middle East and Africa
    • 9.5.1. By Fabric Type
    • 9.5.2. By Gown Type
    • 9.5.3. By Usage Pattern
    • 9.5.4. By End-User
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
        • 9.5.5.1.1. Market Opportunities and Trends
        • 9.5.5.1.2. Growth Prospects
      • 9.5.5.2. Israel
        • 9.5.5.2.1. Market Opportunities and Trends
        • 9.5.5.2.2. Growth Prospects
      • 9.5.5.3. United Arab Emirates
        • 9.5.5.3.1. Market Opportunities and Trends
        • 9.5.5.3.2. Growth Prospects
      • 9.5.5.4. Others
        • 9.5.5.4.1. Market Opportunities and Trends
        • 9.5.5.4.2. Growth Prospects
  • 9.6. Asia Pacific
    • 9.6.1. By Fabric Type
    • 9.6.2. By Gown Type
    • 9.6.3. By Usage Pattern
    • 9.6.4. By End-User
    • 9.6.5. By Country
      • 9.6.5.1. China
        • 9.6.5.1.1. Market Opportunities and Trends
        • 9.6.5.1.2. Growth Prospects
      • 9.6.5.2. Japan
        • 9.6.5.2.1. Market Opportunities and Trends
        • 9.6.5.2.2. Growth Prospects
      • 9.6.5.3. South Korea
        • 9.6.5.3.1. Market Opportunities and Trends
        • 9.6.5.3.2. Growth Prospects
      • 9.6.5.4. India
        • 9.6.5.4.1. Market Opportunities and Trends
        • 9.6.5.4.2. Growth Prospects
      • 9.6.5.5. Australia
        • 9.6.5.5.1. Market Opportunities and Trends
        • 9.6.5.5.2. Growth Prospects
      • 9.6.5.6. Indonesia
        • 9.6.5.6.1. Market Opportunities and Trends
        • 9.6.5.6.2. Growth Prospects
      • 9.6.5.7. Thailand
        • 9.6.5.7.1. Market Opportunities and Trends
        • 9.6.5.7.2. Growth Prospects
      • 9.6.5.8. Taiwan
        • 9.6.5.8.1. Market Opportunities and Trends
        • 9.6.5.8.2. Growth Prospects
      • 9.6.5.9. Others
        • 9.6.5.9.1. Market Opportunities and Trends
        • 9.6.5.9.2. Growth Prospects

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Cardinal Health
  • 11.2. CWS International GmbH
  • 11.3. Molnlycke Health Care AB
  • 11.4. O&M Halyard
  • 11.5. Priontex
  • 11.6. Cortex Products Solution Pvt. Ltd
  • 11.7. Thermo Fisher Scientific
  • 11.8. 3M
  • 11.9. Medica Europe BV
  • 11.10. Whelehan Group
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦